Incidental Detection of Maternal Malignancy by Fetal Cell-Free DNA Screening

Obstetrical & Gynecological Survey(2023)

Cited 9|Views0
No score
Abstract
(Abstracted from Obstet Gynecol 2022;140:121–131) Early detection and targeted treatment of human disorders are the goal of precision medicine. The advancing technology of cell-free DNA (cfDNA) is increasingly being applied in screening, diagnosis, and treatment of several disease processes.
More
Translated text
Key words
maternal malignancy,fetal,dna,cell-free
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined